Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chimerix Inc (NQ: CMRX )

0.9075 +0.0075 (+0.83%)
Streaming Delayed Price Updated: 10:25 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chimerix Inc

< Previous 1 2 3 4 5 6 Next >
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023
From Chimerix, Inc.
Via GlobeNewswire
7 Overlooked Value Stocks That Could Outperform the Market
For those investors seeking bargain opportunities with massive upside potential, these overlooked value stocks should fit the bill. 
Via InvestorPlace
The 7 Best Biotech Stocks to Buy for February 2023
Following the wave of red ink last year, astute investors should target the best biotech stocks to buy this month for strong growth potential. 
Via InvestorPlace
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy. 
Via InvestorPlace
Chimerix: Q2 Earnings Insights
  Chimerix (NASDAQ:CMRX) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix Responds to Rubric Capital Management
Highlights Confidence in Ongoing Strategy and Future Clinical Development Plans 
From Chimerix, Inc.
Via GlobeNewswire
Rubric Capital Management Sends Letter to Chimerix Board of Directors
From Rubric Capital Management LP
Via Business Wire
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases... 
Via Benzinga
Chimerix: Q3 Earnings Insights
Chimerix (NASDAQ:CMRX) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Chimerix beat estimated earnings... 
Via Benzinga
Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 34.7% to $0.0858 in pre-market trading after gaining over 12% on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
We're starting off the day with a look at the latest news behind the biggest pre-market stock movers for Thursday morning! 
Via InvestorPlace
Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
From Chimerix, Inc.
Via GlobeNewswire
Chimerix's Earnings: A Preview
Chimerix (NASDAQ:CMRX) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Chimerix will... 
Via Benzinga
Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022
From Chimerix, Inc.
Via GlobeNewswire
$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones jumped by more than 750 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
Why Chimerix Stock Is Soaring Today
Chimerix Inc (NASDAQ: CMRX) shares are trading higher Monday after the company won a multi-year contract with the Biomedical Advanced Research and Development Authority (BARDA) in the U.S. Department... 
Via Benzinga
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Is Monkeypox Outbreak Cooling? Health Officials Says Virus Transmission Has Slowed
Via Benzinga
Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ. 
Via Benzinga
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher
These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up. 
Via InvestorPlace
Chimerix Earnings Preview
Chimerix (NASDAQ:CMRX) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Chimerix will report... 
Via Benzinga
Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care... 
Via Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
Crude Oil Drops 1%; General Motors Earnings Miss Views
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping more than 200 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Why Is Ayala Pharmaceuticals Trading Higher By Around 130%? 45 Stocks Moving In Tuesday's Mid-Day Session
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) jumped 130% to $2.0001 after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 200 points on Tuesday. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.